Analysis of the Glucocorticoid Toxicity Index (GTI 2.0)
收藏NIAID Data Ecosystem2026-03-13 收录
官方服务：
资源简介：
Analysis of the Glucocorticoid Toxicity Index (GTI 2.0)
应用场景：
创建时间：
2022-01-06
相关数据集
Adverse Events by MedDRA SOC and PT – Part B.
AimNiclosamide is an established anthelmintic substance and a promising candidate for treating cancer, viral infections, and other diseases. However, its solubility in aqueous media is low, and the sy
Figshare2025-02-25 更新60
Subject Disposition at Week 24 (Treated Analysis Set).
*Adverse events leading to study drug discontinuation: Immediate Switch: emergent to EFV/FTC/TDF—anxiety; insomnia; night sweatsDelayed Switch: emergent to ABC/3TC + EFV (baseline to Wk12)—depressionD
Figshare2015-12-03 更新40
Adverse events by day 28, Serious Adverse Events (SAEs) and birth outcomes at 6 weeks post-delivery by study drug.
Adverse events by day 28, Serious Adverse Events (SAEs) and birth outcomes at 6 weeks post-delivery by study drug.
NIAID Data Ecosystem10
COLT2 Medical Review Dataset in A Randomized, Double-Blind, Placebo Controlled Study of the Efficacy of Lithium for Treatment of Pediatric Mania followed by an Open Label Long-Term Safety Period, Double-Blind, Placebo-Controlled Discontinuation Phase and Open Label Restabilization Period
Results of adverse event medical review Study Description The second of two multiphase, multicenter trials that comprehensively examined lithium in the treatment of pediatric patients with bipolar I d
NIAID Data Ecosystem50
Summary of adverse events that occurred in >5% of patients in any treatment group (treated set).
*The preferred adverse event term used for “CF exacerbation” was “cystic fibrosis.”A patient may have been counted in more than one preferred term. Percentages were calculated using the total number o
Figshare2015-12-02 更新30
